New Study Highlights an Experimental Growth Factor That Prevents Knee OA Worsening

Photo of author

(Newswire.net — August 26, 2020) Orlando, FL — More and more studies are emerging about osteoarthritis, which is an extremely common painful condition. Today, there are many scientists who are looking into the various aspects of this disease and how it can be managed.

A study was published in the Journal of the American Medical Association.

In this research, the investigators identified an experimental growth factor called Sprifermin to be useful in preventing the worsening of OA. It has been found to work by increasing the thickness of the knee cartilage.

This interesting study was carried out by Marc C. Hochberg, M.D., from the University of Maryland in Baltimore, and colleagues.

They randomly assigned participants in the FGF-18 Osteoarthritis Randomized Trial with Administration of Repeated Doses (median age, 65 years; 69 percent female) with symptomatic, radiographic knee osteoarthritis to five groups.

These are intra-articular injections of 100 µg of sprifermin administered every six months (110 patients) or every 12 months (110 patients), 30 µg of sprifermin every six months (111 patients) or every 12 months (110 patients), or placebo every six months (108 patients).

The investigators suggest that the increase in the thickness of the cartilage is a positive sign.

More studies are still being carried out to explore the effects of maintaining cartilage health in fighting OA. It is important to realize that OA occurs when there is a deterioration in the health of the joint cartilage.

This is why scientists continuously look into measures that could be beneficial for cartilage health. Doing this may be significantly helpful in reducing the odds of having the condition.

Scientists have been carrying out various research studies to look into the ways in helping OA sufferers manage their condition. Controlling this highly prevalent arthritic condition requires living a healthy diet and lifestyle as well as the use of pain medications.

Pain relievers like nonsteroidal anti-inflammatory drugs (NSAIDs) are widely resorted to by individuals with OA today. However, it is important to realize that their use could also produce some side effects.

The adverse effects are more likely to happen to individuals who frequently use it or utilized it on a long-term basis. 

The good news is that safer alternatives like glucosamine may be useful. This natural ingredient is widely resorted to by sufferers of osteoarthritis due to its remarkable ability to repair the cartilage. It may also help in alleviating pain and enhancing mobility of individuals whose physical abilities are impaired due to OA.

To benefit from its use, it is wise to consider VitaBreeze Glucosamine (http://www.amazon.com/Glucosamine-Chondroitin-Turmeric-Dietary-Supplement/dp/B00DUMO9X4).

About VitaBreeze

VitaBreeze is a nutraceutical brand that manufactures high-quality natural supplements to help people live a healthy, enjoyable, and longer life. All of the company’s products are manufactured in the United States using the finest-quality ingredients that have been carefully selected, tested, and crafted into the firm’s winning formulas. Visit http://www.VitaBreeze.com to learn more.

VitaBreeze

4700 Millenia Blvd
Suite 175 F
Orlando, FL 32839
United States
(407) 545-2239
media@vitabreeze.com
http://www.VitaBreeze.com